Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ludovica Gariazzo"'
Autor:
Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Maria T. Maccallini, Ludovica Gariazzo, Antonella Cosimati, Flaminia Campo, Eleonora Sperandio, Raul Pellini, Diana Giannarelli, Francesco Cognetti
Publikováno v:
European Journal of Cancer. 165:169-173
We previously reported on the immunogenicity and safety of BNT162b2 in a large cohort of patients with cancer after the first and second doses (Di Noia et al., 2021) [1]. Herein, we present result after six months of follow-up.This prospective study
Autor:
Francesco Cognetti, Aldo Morrone, Diana Giannarelli, Domenico Bracco, Raul Pellini, Antonia Marina La Malfa, Laura Conti, Ornella Di Bella, Paolo Carlini, Gianluigi Ferretti, Virginia Ferraresi, Chiara Mandoj, Fabrizio Petrone, Maria Di Santo, Emanuela Taraborelli, Flaminia Campo, Alessandro Monti, Martina Pontone, Ludovica Gariazzo, Maria Teresa Maccallini, Vittoria Barberi, Davide Renna, Fulvia Pimpinelli, Vincenzo Di Noia
Supplementary Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4605351d15b0447794fa9dfdfd79b281
https://doi.org/10.1158/1078-0432.22482476
https://doi.org/10.1158/1078-0432.22482476
Autor:
Francesco Cognetti, Aldo Morrone, Diana Giannarelli, Domenico Bracco, Raul Pellini, Antonia Marina La Malfa, Laura Conti, Ornella Di Bella, Paolo Carlini, Gianluigi Ferretti, Virginia Ferraresi, Chiara Mandoj, Fabrizio Petrone, Maria Di Santo, Emanuela Taraborelli, Flaminia Campo, Alessandro Monti, Martina Pontone, Ludovica Gariazzo, Maria Teresa Maccallini, Vittoria Barberi, Davide Renna, Fulvia Pimpinelli, Vincenzo Di Noia
Purpose:We assessed the immunogenicity and safety of the BNT162b2 vaccine in a large cohort of patients with cancer (CP).Experimental Design:From March 1, 2021 to March 20, 2021, this prospective cohort study included 816 CP afferent to our instituti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::042dd2f6eae2cbd39f65236063b29e7b
https://doi.org/10.1158/1078-0432.c.6530936.v1
https://doi.org/10.1158/1078-0432.c.6530936.v1
Autor:
Flaminia Campo, Antonia La Malfa, Davide Renna, Emanuela Taraborelli, Maria Teresa Maccallini, Fulvia Pimpinelli, Vittoria Barberi, Martina Pontone, Paolo Carlini, Laura Conti, Aldo Morrone, Fabrizio Petrone, Virginia Ferraresi, Ludovica Gariazzo, Raul Pellini, Gianluigi Ferretti, Vincenzo Di Noia, Alessandro Monti, Diana Giannarelli, Domenico Bracco, Chiara Mandoj, Ornella Di Bella, Francesco Cognetti, Maria Di Santo
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(24)
Purpose: We assessed the immunogenicity and safety of the BNT162b2 vaccine in a large cohort of patients with cancer (CP). Experimental Design: From March 1, 2021 to March 20, 2021, this prospective cohort study included 816 CP afferent to our instit
Autor:
Francesca Lo Bianco, Alessandro Parisi, Federica Mazzuca, Ludovica Gariazzo, Giulia Arrivi, Claudia Angela Maria Fulgenzi, Fabio Gelsomino, Corrado Ficorella, Emanuela Dell'Aquila, Michele Ghidini, Andrea Montori, Federica Urbano, Stefano Cascinu, Maria Letizia Calandrella, Michela Roberto, Krisida Cerma, Alessio Cortellini, Marco Di Girolamo, Paolo Marchetti, Margherita Ratti, Alessandro Minelli, Emanuela Pilozzi, Francesco Caputo, Claudio Pizzo
Publikováno v:
Cancers
Volume 12
Issue 9
Cancers, Vol 12, Iss 2457, p 2457 (2020)
Volume 12
Issue 9
Cancers, Vol 12, Iss 2457, p 2457 (2020)
Background: Although most of the analyses included transverse colon cancers (TCC) among right colon cancer (RCC), it is not completely clear if they present total similarities with RCC or if they have their specific features. Therefore, we present an
Autor:
Federica Mazzuca, Emanuela Dell'Aquila, Federica Urbano, F.R. Di Pietro, Fabio Gelsomino, Giulia Arrivi, Corrado Ficorella, F. M. Lo Bianco, Michele Ghidini, Michela Roberto, Ludovica Gariazzo, Alessandro Parisi
Publikováno v:
Annals of Oncology. 31:S203